Your gift is 100% tax deductible
Espa?ol
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Scientists have found a few risk factors that make a person more likely to develop bile duct cancer.
A risk factor is anything that affects your chance of getting a disease like cancer. Different cancers have different risk factors. Some risk factors, like smoking, can be changed. Others, like your age or family history, can¡¯t be changed.
But having a risk factor, or even many risk factors, does not mean that a person will get the disease. And many people who get the disease have few or no known risk factors
Learn more about the risk factors for bile duct cancer and if there are things you can do that might help lower your risk.
Certain conditions of the liver or bile ducts have been found to either cause bile duct cancer or to increase the risk of developing it.
Primary sclerosing cholangitis (PSC) is a condition in which inflammation of the bile ducts (cholangitis) leads to the formation of scar tissue (sclerosis). The cause of the inflammation is not usually known. Many people with PSC also have inflammation of the large intestine, called ulcerative colitis.
Bile duct stones (hepatolithiasis) are a lot like gallstones, but much smaller. They can also cause inflammation that increases the risk of bile duct cancer.
Choledochal cyst disease is a rare condition which some people are born with. It causes bile-filled sacs along the bile ducts. (Choledochal means having to do with the common bile duct.) If not treated, the bile sitting in these sacs causes inflammation of the duct walls. The cells of the duct wall may undergo pre-cancerous changes. Over time, these changes can progress to bile duct cancer.
Liver fluke infections can happen when you eat raw or undercooked fish that is infected with these tiny parasitic worms. In humans, liver flukes live in the bile ducts and can cause bile duct cancer. There are several types of liver flukes. The ones most closely related to bile duct cancer risk are Clonorchis sinensis and Opisthorchis viverrini.
Liver fluke infection is rare in the US, but it is more common in some Southeast Asian countries. It can also affect people who travel to Asia.
Some people have abnormalities where the bile duct and pancreatic duct normally meet.This can allow digestive juices from the pancreas to reflux (flow back) into the bile ducts. This backward flow keeps the bile from moving through the bile ducts the way it should. People with these abnormalities are at higher risk of bile duct cancer.
Cirrhosis is damage to the liver caused by scar tissue. Cirrhosis can be caused by irritants like alcohol and diseases like hepatitis or non-alcoholic fatty liver disease. Studies have found it increases the risk of bile duct cancer.
Infection with hepatitis B virus or hepatitis C virus appears to be associated with increased risk for bile duct cancers. This may be in part because long-term infections with these viruses can also lead to cirrhosis.
Inflammatory bowel disease includes ulcerative colitis and Crohn¡¯s disease. People with these diseases have an increased risk of bile duct cancer.
Genetic disorders are gene-related changes that you are born with. Lynch syndrome, BAP1 tumor predisposition syndrome, cystic fibrosis, and multiple biliary papillomatosis are genetic disorders associated with an increased risk of bile duct cancer.
Older people are more likely than younger people to get bile duct cancer. Most people diagnosed with bile duct cancer are in their 60s or 70s.
In the US, the risk of bile duct cancer is highest among Hispanic ÃÛÌÒ´«Ã½s. Worldwide, bile duct cancer is much more common in Southeast Asia and China, largely because of the high rate of infection with liver flukes in these areas.
Being overweight or obese can increase the risk of cancers of the gallbladder and bile ducts. This could be because obesity increases the risk of gallstones and bile duct stones, as well as the risk of non-alcoholic fatty liver disease. But there may be other ways that being overweight can lead to bile duct cancers, such as changes in certain hormones.
A radioactive substance called Thorotrast (thorium dioxide) was used as a contrast agent for x-rays until the 1950s, when its production and use was banned. It was found to increase the risk for bile duct cancer, as well as other types of liver cancer.
People with diabetes (type 1 or type 2) have been found to have a higher risk of bile duct cancer. It¡¯s unclear whether this is because of high levels of blood sugar or because of other diabetes-associated issues such as obesity or high cholesterol.
People who drink alcohol are more likely to get intrahepatic bile duct cancer. The risk is higher in those who have liver problems from drinking alcohol.
Studies have found other factors may also increase the risk of bile duct cancer. But for these factors, the link to bile duct cancer risk is not as clear.
Other possible risk factors include:
Developed by the ÃÛÌÒ´«Ã½ Cancer Society medical and editorial content team with medical review and contribution by the ÃÛÌÒ´«Ã½ Society of Clinical Oncology (ASCO).
Abou-Alfa GK, Jarnagin W, Lowery M, D¡¯Angelica M, Brown K, Ludwig E, Covey A, Kemeny N, Goodman KA, Shia J, O¡¯Reilly EM. Liver and bile duct cancer. In: Neiderhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff¡¯s Clinical Oncology. 5th ed. Philadelphia, PA. Elsevier; 2014:1373-1395.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. v.4. 2024. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/btc.pdf on September 15, 2024.Patel T, Borad MJ. Carcinoma of the biliary tree. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg¡¯s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, PA. Lippincott Williams & Wilkins; 2015:715-735.
Petrick JL, Campbell PT, Koshiol J, et al. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Br J Cancer. 2018;118(7):1005-1012.
Petrick JL, Yang B, Altekruse SF, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare. PLoS One. 2017:12(10).
Walpole S, Pritchard AL, Cebulla CM, et al. Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide. J Natl Cancer Inst. 2018;110(12):1328-1341. doi:10.1093/jnci/djy171.
Yamada A, Komaki Y, Komaki F, Micic D, Zullow S, Sakuraba A. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis. Lancet Oncol. 2018 Jun;19(6):758-767. doi: 10.1016/S1470-2045(18)30188-8. Epub 2018 Apr 26. PMID: 29706374.
Yeung YP, AhChong K, Chung CK, Chun AY. Biliary papillomatosis: report of seven cases and review of English literature. J Hepatobiliary Pancreat Surg. 2003;10(5):390-5. doi: 10.1007/s00534-002-0837-0. PMID: 14598142.
Last Revised: October 11, 2024
ÃÛÌÒ´«Ã½ Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the ÃÛÌÒ´«Ã½ Cancer Society.
We fund research breakthroughs that save lives. Your year-end gift helps find new treatments for cancer.